Posted by vaccinexchange on April 26, 2012 · Leave a Comment
Earlier this month, the University of Pittsburgh held “A Scientific Symposium Commemorating the 50th Anniversary of the Development of the Polio Vaccine.” One of the speakers at this conference was Dr. Gary Nabel, director of the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases. Dr. Nabel has a pretty nice gig. … Read more
Posted by vaccinexchange on April 19, 2012 · 1 Comment
Forbes currently has an article up that can at best be described as an ode to the HPV vaccine. Uncritically presenting the view of pharmaceutical industries, the article is so incredibly misleading that we thought we would point out some of its fallacies here. The writer begins by describing the case of Neal Fowler, not … Read more
Category Gardasil, HPV, in the media, laws, options, and more, Merck, pharma, vaccine marketing · Tagged with Gardasil, HPV, Merck, vaccine marketing, vaccine policy
Posted by vaccinexchange on April 17, 2012 · 1 Comment
A few weeks ago, we mentioned the way in which vaccine exemptions have been attacked during this past year. We seem to be moving closer and closer to mandatory vaccination and away from the concept of informed consent. You will be glad to know that one of the bills mentioned in that post was amended … Read more
Category exemptions, health policy, in the media, informed consent, laws, options, and more, pharma, vaccine choice, vaccine marketing, Vermont · Tagged with in the media, vaccine exemptions, vaccine policy, Vermont
Posted by vaccinexchange on February 16, 2012 · 2 Comments
Last week’s news about the harassment of FDA scientists and doctors who informed Congress that the FDA was approving risky medical devices showed the lengths to which pharmaceutical industries are willing to go to protect their interests. Even the U.S. Food and Drug Administration – an organization tasked with the protection of American consumers – … Read more
Category chronic fatigue syndrome, in the media, pharma, scientific research, studies, vaccine contamination, Vaccine Injury, Vaccine Science, vaccines · Tagged with chronic fatigue syndrome, Pharma, research and testing, scientific studies, vaccine injury, vaccine science
Posted by vaccinexchange on January 12, 2012 · Leave a Comment
The American Medical Association Journal of Ethics, Virtual Mentor, has devoted its January 2012 issue to the question of vaccine ethics. Unsurprisingly, none of the articles deal with the very real problems that taint vaccine trials and present a false view of vaccine safety. Apparently, using reactive placebos that hide the true rate of serious … Read more
Category in the media, informed consent, laws, options, and more, medical journals, pharma, vaccine choice · Tagged with informed consent, medical journals, vaccine choice, vaccine injury, vaccine policy
Posted by vaccinexchange on January 10, 2012 · 1 Comment
As we explained in our last blog post, the medical profession has an ethical obligation to explain both the risks and the benefits of any drug to a patient so that the patient can make an informed decision about whether or not to follow the doctor’s recommendation. This is particularly true for vaccines, which are … Read more
Category drug trials, Gardasil, HPV, informed consent, medical journals, pharma, scientific research, studies, vaccine choice, Vaccine Injury, vaccine marketing, Vaccine Science, vaccines
Posted by vaccinexchange on January 7, 2012 · Leave a Comment
Any parent or physician can go look up any vaccine package insert on the internet and read how a vaccine is made, what the ingredients are, how the safety study was conducted, how long the subjects were followed after vaccination, and what parameters were being measured to determine efficacy and adverse reactions. That is why I … Read more
Category aluminum adjuvants, autoimmunity, drug research, herd immunity, in the media, neurological issues, NVIC, pharma, placebos, scientific research, studies, thimerosal, vaccination schedule, vaccine choice, vaccines
Posted by vaccinexchange on December 6, 2011 · Leave a Comment
We have been writing about the anthrax vaccine here at Vaccine Xchange for some time. It seems clear that Emergent BioSolutions, the maker of the only human anthrax vaccine (BioThrax) currently available in the US, is working to aggressively market the vaccine, including ensuring that its vaccine is authorized for use for use after inhaling … Read more
Category anthrax, drug trials, pharma, scientific research, studies, vaccine choice, vaccine marketing, Vaccine Science, vaccines · Tagged with anthrax, scientific studies, vaccine marketing, vaccine science
Posted by vaccinexchange on November 4, 2011 · Leave a Comment
The VaccineXchange has been receiving many great suggestions for articles based on peer reviewed published scientific research, news articles, personal experiences and general alerts to events happening in the world of vaccine policy and safety. We want to take the time to thank you for sending us your comments, articles, tweets and other items to … Read more
Posted by vaccinexchange on October 25, 2011 · Leave a Comment
You may have heard that GlaxoSmithKline (GSK) is on the track to coming out with a malaria vaccine. The media has been all over the story: the vaccine supposedly cuts the risk of clinical and severe malaria by 56 and 47% respectively. Natural News points out that, while the vaccine may indeed protect against malaria, … Read more
Category vaccines, new vaccines, in the media, Vaccine Science, studies, videos, placebos, pharma, malaria · Tagged with vaccine science, new vaccine, malaria vaccine, placebos, Natural News, GSK
